Biocorrx Inc. (OTCMKTS:BICX – Get Free Report)’s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.35 and traded as high as $0.35. Biocorrx shares last traded at $0.35, with a volume of 115 shares changing hands.
Biocorrx Stock Performance
The stock’s 50-day moving average is $0.35 and its 200 day moving average is $0.35. The stock has a market capitalization of $10.38 million, a PE ratio of -2.19 and a beta of 0.17.
Biocorrx (OTCMKTS:BICX – Get Free Report) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. The company had revenue of $0.21 million during the quarter, compared to analysts’ expectations of $0.22 million.
About Biocorrx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Further Reading
- Five stocks we like better than Biocorrx
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
